Holen Sie sich die Stockscreener-App
0.644
0.23%
-0.0015
Handel nachbörslich:
.64
-0.004
-0.62%
Schlusskurs vom Vortag:
$0.6455
Offen:
$0.69
24-Stunden-Volumen:
171.56K
Relative Volume:
0.24
Marktkapitalisierung:
$49.51M
Einnahmen:
$241.00K
Nettoeinkommen (Verlust:
$-23.76M
KGV:
-0.5198
EPS:
-1.2389
Netto-Cashflow:
$-18.38M
1W Leistung:
-7.31%
1M Leistung:
+5.23%
6M Leistung:
-8.24%
1J Leistung:
-61.89%
1-Tages-Spanne:
$0.63
$0.69
1-Wochen-Bereich:
$0.63
$0.71
52-Wochen-Spanne:
$0.3625
$1.91
Envoy Medical Inc Stock (COCH) Company Profile
Firmenname
Envoy Medical Inc
Sektor
Branche
Telefon
651-361-8000
Adresse
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COCH
Envoy Medical Inc
|
0.644 | 49.63M | 241.00K | -23.76M | -18.38M | -1.2389 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-06-24 | Eingeleitet | Ascendiant Capital Markets | Buy |
Envoy Medical Inc Aktie (COCH) Neueste Nachrichten
TradingKey - TradingKey
ENVOY MEDICAL (COCH) insiders report 2.46M warrants, 3.10% stake - Stock Titan
Envoy Medical, Inc. Q1 2026 Financial Report: Earnings, Balance Sheet, and FDA-Approved Hearing Devices Overview - Minichart
Envoy Medical Achieves Pivotal Trial Milestone and Secures $78M Financing for Fully Implanted Cochlear Implant FDA Approval Progress - Minichart
Envoy Medical completes pivotal trial enrollment, raises $78m - Investing.com
Envoy Medical, Inc. 1Q 2026: Revenue $39K, Net income ($5.7M), EPS ($0.08) — 10-Q Summary - TradingView
Envoy Medical (NASDAQ: COCH) Q1 2026 loss narrows after $27.8M raise - Stock Titan
Envoy Medical completes pivotal trial enrollment, raises $78m By Investing.com - Investing.com Canada
Envoy Medical reports Q1 2026: $39k revenue, $5.96M operating expenses, $4.35M net loss - TradingView
Envoy Medical (NASDAQ: COCH) boosts cash to $25M as pivotal trial fully enrolls - Stock Titan
56 people get first-of-its-kind fully implanted cochlear implant - Stock Titan
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio - TMX Newsfile
Envoy Medical Reports on First Quarter 2025 Results - TMX Newsfile
Envoy Medical Corporation and Anzu Special Acquisition Corp I Complete Business Combination - TMX Newsfile
Envoy Medical to Participate in the 37th Annual ROTH Conference - TMX Newsfile
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results - Quantisnow
Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up - TMX Newsfile
Envoy Medical (COCH) Expected to Announce Earnings on Thursday - MarketBeat
Envoy Medical presents early data from cochlear implant trial By Investing.com - Investing.com Nigeria
Envoy Medical presents early data from cochlear implant trial - Investing.com
Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant - Yahoo Finance
Envoy Medical Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant - Florida Hospital News and Healthcare Report
Envoy Med (COCH) Stock Industry Update (Selling Pressure) 2026-04-27Momentum Picks - newser.com
Envoy Medical shares crater after announcing $4 million direct offering - MSN
Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial - TMX Newsfile
COCH (Envoy Medical Inc.) reports Q3 2025 EPS below analyst estimates, as shares rise one percent in daily trading.Special Dividend - Cổng thông tin điện tử tỉnh Tây Ninh
A fully implanted cochlear implant clears key step in 56-patient study - Stock Titan
COCHW | Envoy Medical, Inc Warrant Insider Trading - Quiver Quantitative
Envoy Medical appoints Charles S. McKhann to board of directors By Investing.com - Investing.com India
Envoy Medical appoints Charles S. McKhann to board of directors - Investing.com
Envoy Medical appoints Charles S. McKhann as director, joins Compensation Committee - TradingView
Envoy Medical (NASDAQ: COCHW) appoints Charles McKhann as independent director - Stock Titan
Is Envoy Med (COCH) stock a buy on dip opportunity (Breakdown Watch) 2026-04-20Insider Buying - Cổng thông tin điện tử tỉnh Tây Ninh
Envoy Medical Analyst Ratings and Price Targets | NASDAQ:COCH - Benzinga
Envoy Medical (COCH) grants director Chas McKhann 100,000 options - Stock Titan
Envoy Medical (COCH) director Chas McKhann files initial Form 3 ownership - Stock Titan
Envoy Medical adds Chas McKhann to board of directors By Investing.com - Investing.com India
Envoy expects U.S.-Turkey to 'soon' solve issue of sanctions over S-400 defences - marketscreener.com
10-K/A: Annual report (Amendment) - Moomoo
Envoy Medical, Inc. Appoints Chas Mckhann as Independent Director and Compensation Committee Member - marketscreener.com
Envoy Medical adds Chas McKhann to board of directors - Investing.com
Envoy Medical Appoints Chas McKhann to Board of Directors - TMX Newsfile
Envoy taps med-tech veteran tied to $3.4B in exits for board - Stock Titan
Envoy Medical, Inc. Files Amendment No. 1 to 2025 Annual Report (Form 10-K/A): Correction of Auditor Consent Error - Minichart
Envoy Medical (NASDAQ: COCH) amends 10-K, keeps original results - Stock Titan
Is Envoy Med (COCH) Stock Growing Now | Price at $0.62, Up 2.12%High Reward Trade - newser.com
28,934,960 Class A Common Stock of Envoy Medical, Inc. are subject to a Lock-Up Agreement Ending on 13-APR-2026. - marketscreener.com
Risk Hedge: Is Envoy Medical Inc Equity Warrant likely to announce a buyback2026 Trade Ideas & Long-Term Growth Stock Strategies - baoquankhu1.vn
Risk Check: Is Envoy Medical Inc a speculative investment2026 Action & Capital Efficient Trading Techniques - baoquankhu1.vn
COCH SEC FilingsEnvoy Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Finanzdaten der Envoy Medical Inc-Aktie (COCH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):